Surmodics inc (SRDX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
Revenue:
Total revenue

22,822

22,616

30,816

24,344

22,676

22,241

23,038

22,227

19,058

17,013

20,058

17,790

17,503

17,761

18,154

19,972

16,699

16,541

17,364

15,914

14,415

14,205

15,336

14,616

13,604

13,883

14,297

14,289

13,695

13,851

13,843

13,959

12,210

11,916

13,901

12,999

13,334

12,522

18,608

Operating costs and expenses:
Product costs

3,769

3,203

3,659

3,364

3,093

3,523

4,089

4,104

2,913

2,891

3,318

2,914

2,562

2,628

2,839

2,777

2,926

2,366

2,588

2,174

1,955

1,902

2,279

2,037

1,696

2,004

2,004

1,990

1,945

1,959

1,962

2,251

1,615

1,590

2,036

1,302

1,849

1,563

2,388

Research and development

11,935

12,142

14,523

13,321

13,555

11,486

12,590

9,778

10,774

7,831

9,712

7,927

8,208

5,970

5,303

4,693

4,868

3,634

4,326

3,860

4,403

3,576

4,062

3,655

4,134

3,699

3,934

4,009

3,774

3,362

3,490

3,503

3,512

3,638

3,793

3,907

3,800

2,505

4,223

Customer research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,642

Selling, general and administrative

6,733

6,943

7,186

5,939

4,876

5,949

6,506

5,977

6,440

5,188

5,308

5,232

5,076

4,862

5,016

4,483

4,853

3,648

3,518

3,872

3,974

3,542

2,955

3,591

4,294

3,851

2,307

4,052

3,847

3,653

3,753

3,412

3,394

3,466

4,132

3,533

3,473

3,724

4,944

Acquired in-process research and development

-

-

-

-

-

-

-

7,888

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquired intangible asset amortization

541

594

596

599

604

606

613

624

636

618

629

603

591

596

482

806

780

354

166

151

151

151

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contingent consideration gain

-

-

87

104

-317

-35

1,681

106

-2,230

1,118

-546

-629

611

437

1,220

555

-392

109

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Acquisition transaction, integration and other costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

61

640

2,491

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,007

0

0

609

-

Asset impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

191

Total operating costs and expenses

22,978

22,882

26,941

23,327

21,811

21,529

25,479

28,477

18,533

17,646

19,643

16,047

15,826

14,493

14,071

13,375

14,459

12,602

13,098

10,057

10,483

9,171

9,902

9,283

10,124

9,554

8,721

10,051

9,566

8,974

9,205

9,166

8,521

8,694

10,968

8,742

9,122

8,401

16,388

Operating (loss) income

-156

-266

3,875

1,017

865

712

-2,441

-6,250

525

-633

415

1,743

1,677

3,268

4,083

6,597

2,240

3,939

4,266

5,857

3,932

5,034

5,434

5,333

3,480

4,329

5,576

4,238

4,129

4,877

4,638

4,793

3,689

3,222

2,933

4,257

4,212

4,121

2,220

Other (expense) income:
Investment income, net

210

250

247

269

265

316

285

303

142

121

116

104

85

85

27

19

16

1

7

36

56

57

44

42

66

86

80

60

56

72

122

137

143

138

129

147

167

184

241

Interest expense

30

40

40

38

37

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange (loss) gain

-30

-47

35

-42

5

136

126

652

-353

-186

-383

-594

-201

674

-146

234

-434

-135

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment loss on strategic investment

479

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

129

-

-

-

804

-

-

-

-

-

2,577

Gains on strategic investments and other

-

-

-

-

-

-

0

0

0

177

-

-

-

-

-

10

361

-

-

-

-

-

133

28

0

681

1,174

-1,174

119

1,174

-

-

-

-

-

-

-

-

-

Other

0

1

-

-

2

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-40

543

-7

-

-

125

-

-

2

163

-

56

2

162

8

-

171

208

-

298

Other investment capital gains

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

Other (expense) income

-329

164

243

189

235

422

411

955

-211

112

-223

-490

-116

759

17

263

-57

-134

-1,493

-4

599

50

-1,132

70

191

767

21

62

209

1,248

178

139

-499

146

129

318

375

184

-2,038

(Loss) income before income taxes

-485

-102

4,118

1,206

1,100

1,134

-2,030

-5,295

314

-521

192

1,253

1,561

4,027

4,100

6,860

2,183

3,805

2,773

5,853

4,531

5,084

4,302

5,403

3,671

5,096

5,597

4,300

4,338

6,125

4,816

4,932

3,190

3,368

3,062

4,575

4,587

4,305

182

Income tax benefit

-1,947

-250

564

-260

-162

-176

-277

-2,613

-1,220

1,035

-208

533

1,055

1,727

1,523

2,926

1,362

1,152

1,415

1,929

1,480

1,470

1,858

1,729

1,212

1,466

1,864

1,122

918

1,877

1,962

1,758

1,244

1,213

872

1,524

1,763

1,445

1,098

Income from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,674

-

-

-

3,178

3,420

-

2,854

3,174

1,946

2,155

2,190

3,051

2,824

2,860

-

Loss from discontinued operations, net of income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-76

-

-

-

-47

682

-

-55

-30

-344

1,605

-20,855

791

-336

-9,031

-

Loss on sale of discontinued operations, net of income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-59

-82

121

-1,054

-

-

-

-

-

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

682

-

-114

-112

-223

551

-20,855

791

-336

-9,031

-

Net income

1,462

148

3,554

1,466

1,262

1,310

-1,753

-2,682

1,534

-1,556

400

720

506

2,300

2,577

3,934

821

2,653

1,358

3,924

3,051

3,614

2,344

3,598

2,459

3,630

3,686

3,131

4,102

4,248

2,740

3,062

1,723

2,706

-18,665

3,842

2,488

-6,171

-916

Basic income (loss) per share:
Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.27

-

-

-

0.22

0.23

-

0.17

0.18

0.11

0.12

0.14

0.17

0.16

0.16

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-

-

-

0.00

0.05

-

0.00

-0.01

-0.01

0.03

-1.20

0.05

-0.02

-0.52

-

Basic net income per share

0.11

0.01

0.27

0.11

0.09

0.10

-0.14

-0.20

0.12

-0.12

0.04

0.05

0.04

0.17

0.21

0.30

0.06

0.20

0.11

0.30

0.24

0.27

0.18

0.26

0.18

0.26

0.26

0.22

0.28

0.29

0.17

0.17

0.10

0.15

-1.06

0.22

0.14

-0.36

-0.05

Diluted income (loss) per share:
Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.27

-

-

-

0.22

0.23

-

0.17

0.18

0.11

0.12

0.14

0.17

0.16

0.16

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-

-

-

0.00

0.05

-

0.00

-0.01

-0.01

0.03

-1.20

0.05

-0.02

-0.52

-

Diluted net income per share

0.11

0.01

0.26

0.11

0.09

0.09

-0.13

-0.20

0.11

-0.12

0.03

0.05

0.04

0.17

0.20

0.30

0.06

0.20

0.10

0.30

0.23

0.27

0.17

0.26

0.18

0.26

0.25

0.21

0.28

0.29

0.17

0.17

0.10

0.15

-1.07

0.22

0.14

-0.35

-0.05

Weighted average number of shares outstanding:
Basic

13,507

13,469

13,405

13,394

13,390

13,367

13,259

13,203

13,102

13,064

13,037

13,155

13,220

13,200

13,062

12,995

12,969

12,966

12,945

13,002

12,944

13,225

13,649

13,585

13,538

13,756

14,166

14,413

14,622

14,655

16,749

17,528

17,519

17,476

17,449

17,437

17,407

17,383

17,360

Diluted

13,751

13,769

13,778

13,726

13,785

13,827

12,896

13,203

13,465

13,064

13,297

13,385

13,428

13,446

13,216

13,284

13,190

13,186

13,247

13,279

13,207

13,423

13,858

13,813

13,824

14,009

14,408

14,739

14,914

14,863

16,917

17,647

17,632

17,528

17,451

17,529

17,471

17,397

17,360

Product Sales [Member]
Total revenue

11,770

9,974

10,711

9,870

9,887

9,751

10,704

10,475

8,686

8,088

8,826

8,327

7,936

7,701

8,133

7,512

8,173

7,181

6,844

6,583

5,651

5,847

6,166

6,067

5,165

5,400

5,818

5,577

5,758

5,353

5,293

5,748

5,067

4,634

5,607

4,966

5,128

4,449

5,769

Royalties and License Fees [Member]
Total revenue

8,221

10,148

16,806

11,624

9,932

10,096

10,323

9,597

8,428

7,076

9,223

7,244

7,319

8,001

7,996

10,556

6,697

7,954

9,197

7,908

7,383

7,275

8,098

7,385

7,329

7,465

7,480

7,827

6,951

7,516

7,448

7,104

6,283

6,610

7,747

7,478

7,643

7,517

9,356

Research, Development and Other [Member]
Total revenue

2,831

2,494

3,299

2,850

2,857

2,394

2,011

2,155

1,944

1,849

2,009

2,219

2,248

2,059

2,025

1,904

1,829

1,406

1,323

1,423

1,381

1,083

1,072

1,164

1,110

1,018

999

885

986

982

1,102

1,107

860

672

547

555

563

556

-3,483